Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications.

  • Authors : Funkhouser WK Jr; From the Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill (Drs Funkhouser Jr and Banks); Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina (Drs Funkhouser Jr, Hayes, Nikolaishvilli-Feinberg, and Grilley-Olson

Subjects: Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*diagnosis ; Lung Neoplasms/Lung Neoplasms/Lung Neoplasms/*diagnosis ; Mucin-1/Mucin-1/Mucin-1/*metabolism

  • Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2018 Dec; Vol. 142 (12), pp. 1537-1548. Date of Electronic Publication: 2018 Apr 30.Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model:

Record details

×
Academic Journal

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.

  • Authors : Lindeman NI; From the Departments of Pathology (Drs Lindeman and Sholl) and Medicine (Dr Kwiatkowski), Brigham and Women's Hospital, Boston, Massachusetts; the Cancer Center (Dr Bernicker) and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle)

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Lung Neoplasms/Lung Neoplasms/Lung Neoplasms/*drug therapy ; Molecular Targeted Therapy/Molecular Targeted Therapy/Molecular Targeted Therapy/*methods

  • Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2018 Mar; Vol. 142 (3), pp. 321-346. Date of Electronic Publication: 2018 Jan 22.Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model:

Record details

×
Academic Journal

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*analysis ; Immunohistochemistry/Immunohistochemistry/Immunohistochemistry/*methods ; Immunohistochemistry/Immunohistochemistry/Immunohistochemistry/*standards

  • Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2018 Mar; Vol. 142 (3), pp. 408-419. Date of Electronic Publication: 2017 Jul 07.Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model:

Record details

×
Academic Journal

Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.

  • Authors : Driver BR; From the Departments of Pathology and Genomic Medicine (Drs Driver, R.A. Miller, T. Miller, Deavers, Gorman, Mody, Ge, Barrios, and Cagle), Medicine (Dr Bernicker), and Surgery (Dr Kim), Houston Methodist Hospital, Houston, Texas.; Miller RA

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*metabolism ; B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*metabolism ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism

  • Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2017 Nov; Vol. 141 (11), pp. 1529-1532. Date of Electronic Publication: 2017 Aug 22.Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model:

Record details

×
Editorial & Opinion

First-Line Immune Therapy-Implications for Pathologists.

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*drug therapy ; Drug Therapy/Drug Therapy/Drug Therapy/*methods

  • Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2016 Aug; Vol. 140 (8), pp. 739-40.Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Print

Record details

×
Academic Journal

Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics ; DNA, Neoplasm/DNA, Neoplasm/DNA, Neoplasm/*genetics ; Lung Neoplasms/Lung Neoplasms/Lung Neoplasms/*genetics

  • Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2016 Aug; Vol. 140 (8), pp. 825-9. Date of Electronic Publication: 2016 May 19.Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model:

Record details

×
Academic Journal

Folate Receptor α Expression Level Correlates With Histologic Grade in Lung Adenocarcinoma.

  • Authors : Driver BR; From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Driver, Barrios, Ge, Haque, and Cagle); and Biocare Medical LLC, Concord, California (Dr Tacha).

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*metabolism ; Folate Receptor 1/Folate Receptor 1/Folate Receptor 1/*metabolism ; Lung Neoplasms/Lung Neoplasms/Lung Neoplasms/*metabolism

  • Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2016 Jul; Vol. 140 (7), pp. 682-5. Date of Electronic Publication: 2015 Nov 24.Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model:

Record details

×
Academic Journal

Clinical Validation of a Novel Commercial Reverse Transcription-Quantitative Polymerase Chain Reaction Screening Assay for Detection of ALK Translocations and Amplifications in Non-Small Cell Lung Carcinomas.

  • Authors : Liu C; From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas. Dr Portier is now with Roche Tissue Diagnostics/Ventana Medical Systems (ROCHE Group), Tucson, Arizona.; Pepper K

Subjects: Gene Amplification* ; Translocation, Genetic*; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*genetics

  • Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2016 Jul; Vol. 140 (7), pp. 690-3. Date of Electronic Publication: 2015 Nov 24.Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model:

Record details

×
  • 1-10 of  49 results for ""Cagle PT""